Effects of menstrual history and use of medications on bone mineral density: The EVOS study

Calcified Tissue International

Volumn 63, Issue 4, 1998, Pages 271-276

  Masaryk, P ^a   Lunt, M ^b   Benevolenskaya, L ^c   Cannata, J ^d   Dequeker, J ^l   Dohenhof, C ^e   Falch, J A ^f   Felsenberg, D ^g   Pols, H A P ^h   Poor, G ⁱ   Reid, D M ^l   Scheidt Nave, C ^j   Weber, K ^k   O'Neill, T ^l   Silman, A J ^l   Reeve, J ^b  

^a Research Institute for Rheumatic Diseases   (Slovakia)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c V A NASONOVA RESEARCH INSTITUTE OF RHEUMATOLOGY   (Russian Federation)

^d HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^e Klinik für Orthopädie   (Germany)

^f AKER UNIVERSITY HOSPITAL   (Norway)

^g FREIE UNIVERSITÄT BERLIN   (Germany)

^h ERASMUS MEDICAL CENTER   (Netherlands)

ⁱ National Institute of Rheumatology Budapest   (Hungary)

^j Medizinische Klinik und Poliklinik   (Germany)

^k UNIVERSITY HOSPITAL GRAZ   (Austria)

^l NONE

more..

Author keywords

Bone mineral density; Epidemiology; Medication use; Menopause; Osteoporosis

Indexed keywords

ANABOLIC AGENT; CALCITONIN; CALCIUM; FLUORIDE; GLUCOCORTICOID; ORAL CONTRACEPTIVE AGENT; VITAMIN D;

ADULT; ARTICLE; BONE DENSITY; BONE MINERAL; DENSITOMETRY; EUROPE; FEMALE; GEOGRAPHY; HORMONE SUBSTITUTION; HUMAN; MALE; MENOPAUSE; MENSTRUATION; NORMAL HUMAN; OSTEOPOROSIS; PRIORITY JOURNAL; REGRESSION ANALYSIS;

AGE FACTORS; AGED; ANABOLIC AGENTS; BONE DENSITY; CALCITONIN; CALCIUM, DIETARY; CONTRACEPTIVES, ORAL; DENSITOMETRY, X-RAY; EUROPE; FEMALE; FLUORIDES; GLUCOCORTICOIDS; HORMONE REPLACEMENT THERAPY; HUMANS; MALE; MENSTRUATION; MIDDLE AGED; OSTEOPOROSIS; OSTEOPOROSIS, POSTMENOPAUSAL; SEX FACTORS; VITAMIN D;

EID: 0031693540     PISSN: 0171967X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002239900525     Document Type: Article

References (26)

1. Cooper C, O'Neill T, Silman A, on behalf of the European Vertebral Osteoporosis Study Group (1993) The epidemiology of vertebral fractures. Bone 14 (suppl 1):S89-S97
2. Johnell O, Gullberg B, Allander E, Kanis JA, and the MEDOS Study Group (1992) The apparent incidence of hip fracture in Europe, Osteoporosis Int 2:298-302
3. O'Neill TW, Felsenberg D, Varlow J, Cooper C, Kanis JA, Silman AJ, and the European Vertebral Osteoporosis Study Group (1996) The prevalence of vertebral deformity in European men and women: the European Vertebral Osteoporosis Study. J Bone Miner Res 11:1010-1017
4. Lunt M, Felsenberg D, Adams J, Benevolenskaya L, Cannata J, Dequeker J, Dodenhof C, Falch JA, Johnell O, Khaw K-T, Masaryk P, Pols HAP, Poor G, Reid D, Scheidt-Nave C, Weber K, Silman AJ, Reeve J (1997) Population-based geographic variations in DXA bone density in Europe: the EVOS Study. Osteoporosis Int 7:175-189
5. O'Neill TW, Silman AJ, Naves Diaz M, Cooper C, Kanis JA, Felsenberg D, and the European Vertebral Osteoporosis Study Group (1997) Influence of hormonal and reproductive factors on the risk of vertebral deformity in European women. Osteoporosis Int 7:72-78
6. Kanis JA, Johnell J, Gullberg B, Allander E, Dilsen G, Gennari C, Lopes Vaz A, Lyritis G, Mazzuoli G, Miravet L, Passeri M, Perez Cano R, Rapade A, Ribot C (1992) Evidence for efficacy of drugs affecting bone metabolism in preventing hip fracture. Br Med J 305:1124-1128
7. Mazzuoli GF, Gennari C, Passeri M, Acca M, Camporeale A, Piolo G (1993) Hip fracture in Italy: epidemiology and preventive efficacy of bone-active drugs. Bone 14:S81-S84
8. Herrala J, Puolojoki H, Impivaara O, Liippo K, Tala E, Nieminen M (1994) Bone mineral density in asthmatic women on high-dose inhaled beclomethasone dipropionate. Bone 15: 621-623
9. Kröger H, Honkanen R, Saarikoski S, Alhava E (1994) Decreased axial bone mineral density in perimenopausal women with rheumatoid arthritis - a population-based study. Ann Rheum Dis 53:18-23
10. Lane N, Pressman A, Star V, Cummings S, Nevitt M, and the Study of Osteoporotic Fractures Research Group (1995) Rheumatoid arthritis and bone mineral density in elderly women. J Bone Miner Res 10:257-263
11. Cooper C, Coupland C, Mitchell M (1995) Rheumatoid arthritis, corticosteroid therapy and hip fracture. Ann Rheum Dis 54:49-52
12. Pearson J, Dequeker J, Henley M, Bright J, Reeve J, Kalender W, Laval-Jeantet AM, Ruegsegger P, Felsenberg D, Adams J, Birkenhager JC, Braillon P, Diaz Curiel M, Fischer M, Galan F, Geusens P, Hyldstrup L, Jaeger P, Jonson R, Kalef-Ezras J, Kotzki P, Kroger H, van Lingen A, Nilsson S, Osteaux M, Perez Cano R, Reid DM, Reiners C, Ribot C, Schneider P, Slosman DO, Wittenberg G (1995) European semi-anthropomorphic spine phantom for the calibration of bone densitometers: assessment of precision, stability and accuracy. Osteoporosis Int 5:174-184
13. Dequeker J, Reeve J, Pearson J, Bright J, Felsenberg D, Kalender W, Langton C, Laval-Jeantet AM, Ruegsegger P, Van de Perre G, and the COMAC-BME Quantitative Assessment of Osteoporosis Study Group (1993) Multicentre European COMAC-BME study on the standardisation of bone densitometry procedures. Technol Health Care 1:127-131
14. O'Neill TW, Cooper C, Algra D, Pols HAP, Agnusdei D, Dequeker J, Felsenberg D, Kanis JA, Kruskemper G, Raspe H, Seelbach H, Silman AJ, on behalf of the European Vertebral Osteoporosis Study Group (1995) Design and development of a questionnaire for use in a multicentre study of vertebral osteoporosis in Europe: the European Vertebral Osteoporosis Study (EVOS). Rheumatol Eur 24:75-81
15. Maldonado G, Greenland S (1993) Simulation study of confounder-selection strategies. Am J Epidemiol 138:923-936
16. Poor G, Atkinson EJ, O'Fallon WM, Melton LJ III (1995) Predictors of hip fractures in elderly men. J Bone Miner Res 10:1900-1907
17. Davis JW, Ross PD, Johnson NE, Wasnich RD (1995) Estrogen and calcium supplement use among Japanese-American women: effects upon bone loss when used singly and in combination. Bone 17:369-373
18. Lindsay R, Thome J, Kanders B (1986) The effect of oral contraceptive use on vertebral bone mass in pre- and postmenopausal women. Contraception 33:333-340
19. Cramer D, Xu H, Harlow B (1995) Does "incessant" ovulation increase risk for early menopause? Am J Obstet Gynecol 172:568-573
20. Cooper C, Hannaford P, Croft P, Kay CR (1993) Oral contraceptive pill use and fractures in women: a prospective study. Bone 14:41-45
21. Kleerekoper M, Brienza RS, Schultz LR, Johnson CC (1991) Oral contraceptive use may protect against low bone mass. Arch Intern Med 151:1971-1976
22. Laitinen K, Valimaki M, Keto P (1991) Bone mineral density measured by dual-energy x-ray absorptiometry in healthy Finish women. Calcif Tissue Int 48:224-231
23. Tuppurainen M, Kröger H, Saarikoski S, Honkanen R, Alhava E (1994) The effect of previous oral contraceptive use on bone mineral density in perimenopausal women. Osteoporosis Int 4:93-98
24. Dequeker J, de Muylder E (1982) Long-term progestogen treatment and bone remodelling in peri-menopausal women: a longitudinal study. Maturitas 4:309-313
25. Garnero P, Sornay-Rendu E, Delmas PD (1995) Decreased bone turnover in oral contraceptive users. Bone 16:499-503
26. Prior JC, Vigna YM, Barr SI, Kennedy S, Schulzer M, Li DKB (1996) Ovulatory premenopausal women lose cancellous spinal bone: a five-year prospective study. Bone 18:261-267